Oncology News

Cumulative exposure to immunomodulators increased the risk for high-grade cervical intraepithelial neoplasia and cervical cancer in women with inflammatory bowel disease, according to data from Alimentary Pharmacology & Therapeutics.

CHICAGO — A chemotherapy de-escalation strategy involving dual HER2 blockade resulted in high rates of 3-year invasive DFS among patients with HER2-positive early breast cancer, according to study results presented at ASCO Annual Meeting.

Kristin E. Rojas, MD, FACS, FACOG, is working to shed light on and address the multifaceted needs of female patients with cancer and survivors, including sexual dysfunction, with the Menopause Urogenital Sexual Health and Intimacy Clinic.

A smartphone app-assisted postoperative monitoring intervention improved quality of recovery after cancer surgery, according to results of a study conducted at University of Calgary.

BALTIMORE — A late-breaking session at the ACOG Annual Clinical & Scientific Meeting highlighted FDA updates in breast density reporting that include a lay summarization for patients while ACOG clinical guidance on breast density remains unchanged.

Women with breast cancer whose BMI fell in the overweight or obese ranges achieved meaningful weight loss via a telephone-based intervention, according to phase 3 study results.

Cervical cancer screening rates are low across the board, but disparities for Black patients persist, according to researchers.

Black women with HER2-positive breast cancer and brain metastases appeared at higher risk for mortality than their white counterparts, according to study results published in Journal of the National Comprehensive Cancer Network.

President Joe Biden today announced his intention to nominate NCI director Monica M. Bertagnolli, MD, FACS, FASCO, as director of the NIH.

Prostate cancer may be more common among transgender women than case reports suggest, according to a study published in JAMA that estimated risk at approximately 14 cases per 10,000 people.